Nurse Practitioner · Tampa, FL
NPI
1174853923
Since 2009
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
3000 Medical Park Dr, Suite 150
Tampa, FL, 33613
Phone (813) 977-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
516 services
Medicare patients, 2024
167
Average age 72
Drug cost, 2024
$2.9M
3,520 prescriptions
Company payments, 2025
$2,285
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lisa M Gavosto was code 99214 (office e&m - established), 220 times for 125 patients. In total Lisa M Gavosto billed 516 services in 15 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 220 | 125 | $73.25 | $16K |
| 95251 Test - Miscellaneous | Office | 93 | 49 | $20.79 | $1,933 |
| 82962 Clinical Chemistry | Office | 66 | 44 | $3.21 | $212 |
| 99213 Office E&M - Established | Office | 41 | 33 | $49.02 | $2,010 |
| 36415 Venipuncture Blood Collection | Office | 30 | 22 | $8.65 | $260 |
| 99215 Office E&M - Established | Office | 28 | 14 | $108.28 | $3,032 |
| 83036 Blood Count | Office | 25 | 20 | $9.52 | $238 |
By year: 2022 $32K for 656 services; 2023 $30K for 632 services; 2024 $25K for 516 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 66 | 44 | $3.21 | $212 |
| 36415 Venipuncture Blood Collection | 30 | 22 | $8.65 | $260 |
| 83036 Blood Count | 25 | 20 | $9.52 | $238 |
Medicare prescription drug claims, 2024
In 2024, the drug Lisa M Gavosto prescribed most often to Medicare patients was Levothyroxine Sodium, with 289 prescriptions and refills. In total Lisa M Gavosto wrote 3,520 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 289 | 740 | 87 | $2,526 |
| Mounjaro Tirzepatide | 226 | 285 | 36 | $294K |
| Ozempic Semaglutide | 152 | 218 | 38 | $201K |
| Synthroid Levothyroxine Sodium | 149 | 305 | 37 | $13K |
| Metformin Hcl Generic | 127 | 295 | 34 | $742 |
| Tresiba Flextouch U-200 Insulin Degludec | 116 | 263 | 37 | $162K |
| Pioglitazone Hcl Generic | 115 | 272 | 32 | $894 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 112 | 258 | 45 | $11K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 90 | 184 | 29 | $12K |
| Jardiance Empagliflozin | 90 | 159 | 25 | $89K |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 86 | 154 | 19 | $88K |
| Farxiga Dapagliflozin Propanediol | 85 | 154 | 22 | $85K |
| Metformin Hcl Er Metformin Hcl | 84 | 217 | 24 | $459 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 79 | 158 | 22 | $63K |
| Humalog Kwikpen U-100 Insulin Lispro | 70 | 134 | 30 | $19K |
Brand drugs: 2,121 claims; generic drugs: 1,046 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lisa M Gavosto $2,285 ($2,285 in general payments such as food, travel and fees) from 32 companies. The largest payer was Novo Nordisk Inc with $250.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 14 | $250 |
| Corcept Therapeutics CORT | 12 | $209 |
| Recordati_rare_diseases_inc. | 8 | $153 |
| Medtronic, Inc. MDT | 5 | $147 |
| Ascendis Pharma Endocrinology Inc ASND | 6 | $145 |
| Amgen Inc. AMGN | 9 | $139 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $125 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $113 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $107 |
| Xeris Pharmaceuticals, Inc. | 4 | $80.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.